UCLA Health: Targeted Therapy Drug Shows Early Promise Against KRAS-Driven Lung and Pancreatic Cancers
April 28, 2026
April 28, 2026
LOS ANGELES, California, April 28 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers
Study co-led by UCLA suggests a potential new treatment approach for KRAS G12D, a key driver of lung and pancreatic cancer with few current treatment options
*
A first-in-human clinical trial led by an international team of researchers and pu . . .
* * *
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers
Study co-led by UCLA suggests a potential new treatment approach for KRAS G12D, a key driver of lung and pancreatic cancer with few current treatment options
*
A first-in-human clinical trial led by an international team of researchers and pu . . .